SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pull_da_trigger who wrote (732)11/9/2001 11:21:35 AM
From: scaram(o)uche   of 2243
 
The portfolios at T/FIF?........ they have a track record of success before and after being abandoned.

Compounding the portfolios would have yielded mega bucks. Go through the three threads and picture the compounded returns.

Portfolios sometimes resemble my current preferences and personal portfolio, sometimes there is little resemblance. My primary focus is to sweep profit from public markets into private biotech equity, and I frequently overweight trading positions that are not reflected in any SI portfolio.

There are two portfolios which are now actively managed.

Portfolio "2000" is up 334% in just over seven quarters. Portfolio "2001" is up better than 33% YTD. If you pick a single biotech that beats the portfolio(s), it could reflect expertise, or it could be luck.

I neither reject nor accept your dare, as I have no interest in it. You're on ignore going forward, but I wish you immense success. And, again, I sincerely hope that research at Oncolytics is successful.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext